Abstract
dc:description.abstractAt the United Nations General Assembly, Bangladesh committed to providing tuberculosis preventive treatment to approximately one million high-risk individuals, including close household contacts of tuberculosis patients, between 2023 and 2027. Since the commitment, the funding landscape in global health has changed amid global politics. Therefore, in a resource-constrained environment like Bangladesh, it is crucial to identify suitable implementation tools that are not resource-intensive and maximize input efficiency. This thesis looks at three areas related to TB infection: how well three different skin tests detect TB infection for their cost, which of two treatment options works better for treating TB infection, and whether people manage their treatment better on their own or with the help of a digital reminder tool. The results showed that a 3-month treatment taken once a week (isoniazid with rifapentine) works better and costs less than a 3-month treatment taken every day (isoniazid and rifampicin). Among the skin tests, the two newer options, Diaskintest and Cy-TB, were both better and cheaper than the older standard test (the Tuberculin skin test). The digital reminder tool costs more than letting people manage treatment on their own, but it also leads to better health outcomes: it costs about USD 830 to gain one extra year of healthy life when using the digital tool.
Degree
thesis:*- Department dc:contributor.department
- Health Policy
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Pushpita Samina
- Advisors dc:contributor.advisor
-
- Guindon, Emmanuel
- Tarride, Jean Eric
- Hurley, Jeremiah
- Zwerling, Alice
Subjects
dc:subject × 4Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.71548/25524